Improving the efficacy of antibody-based cancer therapies. [electronic resource]
Producer: 20020416Description: 118-29 p. digitalISSN:- 1474-175X
- Animals
- Antibodies -- immunology
- Antibodies, Bispecific -- therapeutic use
- Antibodies, Monoclonal -- immunology
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal, Murine-Derived
- Antibodies, Neoplasm -- immunology
- Antibody-Dependent Cell Cytotoxicity
- Antigens, Neoplasm -- immunology
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Combined Modality Therapy
- Cytokines -- administration & dosage
- Drug Delivery Systems
- Humans
- Immunization, Passive
- Immunoconjugates -- therapeutic use
- Immunotherapy -- methods
- Immunotoxins -- therapeutic use
- Liposomes
- Mice
- Neoplasm Proteins -- antagonists & inhibitors
- Neoplasm, Residual
- Neoplasms -- drug therapy
- Neovascularization, Pathologic -- immunology
- Prodrugs -- administration & dosage
- Protein Engineering
- Radioimmunotherapy
- Recombinant Fusion Proteins -- immunology
- Rituximab
- Trastuzumab
- Treatment Outcome
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.